eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
2/2020
vol. 24
 
Share:
Send email
Share:
abstract:
Original paper

The incidence of nausea and vomiting in cancer patients in Greek clinical practice: A longitudinal study

Maria Lavdaniti
1
,
Nikoletta Margari
2
,
Aikaterini Chavela
3
,
Michalis Mantzanas
4
,
Ioanna Chatzi
5
,
Evangelos C. Fradelos
6
,
Ioannis Tilaveridis
7
,
George Tzavelas
3

  1. Nursing Department, International Hellenic University, Thessaloniki, Greece
  2. Nursing Department, University of West Attica, Athens, Greece
  3. Department of Statistics and Insurance Science, University of Piraeus, Piraeus, Greece
  4. Director of Nursing, General Hospital of Nea Ionia “Konstantopouleio-Patision”, Athens, Greece
  5. Medical Department General Hospital of Nea Ionia "Konstantopouleio-Patision", Athens, Greece
  6. Psychiatric Department, “Sotiria” Athens General Hospital for Chest Diseases, Athens, Greece
  7. Department of Oral and Maxillofacial Surgery, School of Dentistry, Aristotle University of Thessaloniki, Thessaloniki, Greece
Contemp Oncol (Pozn) 2020; 24 (2): 112-117
DOI: https://doi.org/10.5114/wo.2020.95853
Online publish date: 2020/06/08
View full text Get citation
 
PlumX metrics:
Aim of the study
To assess nausea and vomiting in cancer patients during two cycles of chemotherapy, and the impact on their quality of life.

Material and methods
A longitudinal study was conducted in an oncology department of a large general public hospital in Northern Greece. The sample consisted of 200 cancer patients. Data were collected with the MASCC-Antiemesis Tool and FACT-G questionnaire and specific demographic and clinical characteristics.

Results
In cycle 2, acute vomiting was experienced by 16% of the patients and delayed vomiting by 14%; acute nausea was experienced by 27.5% and delayed nausea by 38%. In cycle 3, acute and delayed vomiting were experienced by 17.5% and 15% of the patients, respectively, acute nausea by 29.5%, and delayed nausea by 36.5%. The comparison of severity in acute vomiting between cycle 2 and cycle 3 yielded a statistically significant (p = 0.003) difference; similar results were obtained in the comparison of severity of acute nausea (p < 0.001). The correlation of severity of acute nausea with physical, emotional, and functional well-being as well as the total score of quality of life in two measurement points was statistically significant (p < 0.005). Multiple forward linear regression analysis showed that the total score of quality of life was significantly associated with age, gender, educational status, occupational status, type of cancer, family status, and diet.

Conclusions
Our study confirms that nausea and vomiting are significant clinical problems that influence quality of life. Further research is needed to evaluate the predictors of acute and delayed nausea and vomiting during chemotherapy.

keywords:

nausea, vomiting, chemotherapy, quality of life, Northern Greece
FEATURED PRODUCTS
BOOKS
• Genetyka i leczenie chłoniaka rozlanego z dużych komórek B (DLBCL)
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.